REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN)

1,093 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2021.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 947 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 79.7M shares of 105M outstanding shares and own 75.94% of the company stock.
Largest 10 shareholders include FMR LLC (10.9M shares), VANGUARD GROUP INC (7.97M shares), Capital World Investors (5.31M shares), STATE STREET CORP (4.52M shares), WELLINGTON MANAGEMENT GROUP LLP (4.06M shares), JPMORGAN CHASE & CO (3.79M shares), LOOMIS SAYLES & CO L P (2.75M shares), GEODE CAPITAL MANAGEMENT, LLC (1.71M shares), HARRIS ASSOCIATES L P (1.45M shares), and Capital International Investors (1.29M shares).
This table shows the top 947 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.